Methods |
RCT |
|
Participants |
18 participants with P. falciparum
|
|
Interventions |
A: MQ 750 mg B: MQ 750 mg + SP (1500 mg/75 mg) C: MQ 750 mg + PQ 45 mg All single doses Follow-up: 28 days for gametocytes and 21 days for infectiousness |
|
Outcomes |
Gametocyte prevalence at days 3, 8, 14, and 21 Infectiousness to An. dirus Sporozoite infections in mosquitoes Infectivity of sporozoite-infected mosquitoes to subsequent patients |
|
Notes |
Only abstract available. Mosquitoes fed on the patients were allowed to develop sporozoites which were then fed on uninfected people. One of the MQ + PQ group passed the infection to a new person. |
|
Risk of bias |
|
Bias |
Authors' judgement |
Support for judgement |
|
Random sequence generation (selection bias) |
Unclear risk |
Trial authors stated it was randomized in abstract. |
|
Allocation concealment (selection bias) |
Unclear risk |
No information in abstract. |
|
Incomplete outcome data (attrition bias) All outcomes |
Low risk |
All patients were followed up. |
|
Selective reporting (reporting bias) |
Unclear risk |
No information in abstract. |
|
Other bias |
Unclear risk |
None known. |
|
Blinding of participants and personnel (performance bias) All outcomes |
Low risk |
Stated to be double blind in title. |
|
Blinding of outcome assessment (detection bias) All outcomes |
Unclear risk |
No information in abstract. |